AVE 0.00% 0.3¢ avecho biotechnology limited

wow, page-91

  1. 10,009 Posts.
    Jackpot, I don't flollow PRR. Closely. It is a far higher risk profile than POH. It may well turn into a huge success.

    POH. Is much closer to the pot of GOLD. It's a long hard process getting FDA. Approval. Ask any ACL holder about that.

    With POH chasing COSMACEUTICALS and. NUTRACEUTICALS. It is very rapid path to the cash.

    AOD-9064. Cellulite cream. Was 20 months from CONCEPT to First Sale.

    PRR. Will take longer than that from final FDA. Submission to first sale.

    Both are good, but POH. Is much broader and faster.Chasing bigger markets.

    PoS
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.